Plasma Proteome Signatures in Sickle Cell Anemia and the Effect of Hydroxyurea Treatment
Journal of Proteome Research · 2026
DOI: 10.1021/acs.jproteome.6c00158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2026. Verfasst von Neha Kumari und 14 weiteren Autor:innen. Beteiligte Einrichtung: CSIR-Centre for Cellular and Molecular Biology , Hyderabad, Telangana500007, India. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Hydroxyurea, Proteome, Blood Proteins. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Science and Engineering Research Board, CSIR-Centre for Cellular and Molecular Biology, Hyderabad.
Abstract (Originalsprache)
Sickle Cell Anaemia (SCA) is a monogenic blood disorder caused by a mutation in the β-globin gene, yet it presents with marked clinical variability. Although hydroxyurea (HU) is an established therapy, its precise mechanism of action remains incompletely understood. Plasma proteins represent valuable biomarkers for elucidating disease mechanisms and treatment responses. In this study, plasma proteome profiling of 31 healthy controls and 76 SCA patients identified 43 differentially abundant proteins (DAPs) that form a highly interconnected interaction network. Proteins with increased abundance in SCA were largely associated with immune and inflammatory responses, whereas those with reduced levels were linked to coagulation and proteolytic pathways. HU therapy was associated with elevated levels of haptoglobin (HP) and hemopexin (HPX), key mediators of free hemoglobin scavenging. We also identified several previously unreported plasma proteins altered in SCA, broadening the landscape of potential biomarkers and HU-responsive targets. Many DAPs significantly correlated with clinical indices, such as transfusion frequency, vaso-occlusive crises, white blood cell counts, and platelet counts, offering insights into disease mechanisms and potential utility in disease management. Notably, overlap with β-thalassemia-associated signatures suggests shared pathophysiological pathways between these hemoglobinopathies. Collectively, these findings provide a strong foundation for translational validation in larger, independent cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CSIR-Centre for Cellular and Molecular Biology , Hyderabad, Telangana500007, India.
- Pt. Deendayal Upadhyay Memorial Health Science and Ayush University of Chhattisgarh , Naya Raipur, Chhattisgarh493661, India.
- Arihant Multispeciality Hospital, Nagpur, Maharashtra440026, India.
ORCID-Profile: Gopinath Palanisamy, Sristi Chakroborty, Giriraj Ratan Chandak
Förderung
- Council of Scientific and Industrial Research, India
- Science and Engineering Research Board
- CSIR-Centre for Cellular and Molecular Biology, Hyderabad
Zitieren
APA
Kumari, N., Paliwal, S., Umesh, A., Palanisamy, G., Marneni, J., Chakroborty, S., Bakthisaran, R., Yele, K., K, R. K., Nongmaithem, S. S., Punyasri, P. S. K. D. B., Patra, P. K., Jain, D., Raychaudhuri, S., & Chandak, G. R. (2026). Plasma Proteome Signatures in Sickle Cell Anemia and the Effect of Hydroxyurea Treatment. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.6c00158
Vancouver
Kumari N, Paliwal S, Umesh A, Palanisamy G, Marneni J, Chakroborty S, et al. Plasma Proteome Signatures in Sickle Cell Anemia and the Effect of Hydroxyurea Treatment. Journal of Proteome Research. 2026. doi:10.1021/acs.jproteome.6c00158
BibTeX
@article{Kumari2026,
author = {Kumari, Neha and Paliwal, Sumit and Umesh, Anushri and Palanisamy, Gopinath and Marneni, Jayalakshmi and Chakroborty, Sristi and Bakthisaran, Raman and Yele, Kameswari and K, Ranjith Kumar and Nongmaithem, Suraj Singh and Punyasri, Pasupuleti Sri Kanya Durga Bhavani and Patra, Pradeep K and Jain, Dipty and Raychaudhuri, Swasti and Chandak, Giriraj Ratan},
title = {Plasma Proteome Signatures in Sickle Cell Anemia and the Effect of Hydroxyurea Treatment},
journal = {Journal of Proteome Research},
year = {2026},
doi = {10.1021/acs.jproteome.6c00158}
}
EUVIMED